AstraZeneca to join Rigel in asthma drug venture – The News Journal


Proactive Investors USA & Canada

AstraZeneca to join Rigel in asthma drug venture
The News Journal
AstraZeneca will join with Rigel Pharmaceutical Inc. to develop a treatment for chronic asthma that could be worth $100 million, if the drug can manage the
AstraZeneca partners with Rigel on asthma drugCBS News
AstraZeneca and Rigel strike asthma deal worth up to $100MFierceBiotech
AstraZeneca And Rigel Sign Worldwide License Agreement For A MarketWatch (press release)
NASDAQ –Proactive Investors USA & Canada –RTT News
all 37 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.